• LAST PRICE
    31.7500
  • TODAY'S CHANGE (%)
    Trending Down-0.4700 (-1.4587%)
  • Bid / Lots
    30.6000/ 1
  • Ask / Lots
    34.1300/ 1
  • Open / Previous Close
    32.2200 / 32.2200
  • Day Range
    Low 31.2300
    High 32.6600
  • 52 Week Range
    Low 29.7200
    High 76.9800
  • Volume
    264,641
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 32.22
TimeVolumeIMCR
09:32 ET154232.44
09:35 ET10032.38
09:37 ET10032.385
09:51 ET10032.195
09:53 ET50032.18
09:55 ET870431.39
09:57 ET50031.605
10:00 ET149731.63
10:02 ET20031.71
10:06 ET29531.7656
10:09 ET120031.415
10:11 ET20031.23
10:13 ET1069131.595
10:15 ET170031.665
10:18 ET60031.565
10:20 ET150231.78
10:22 ET10031.8
10:24 ET60031.81
10:26 ET40031.835
10:27 ET385931.785
10:31 ET20031.7
10:36 ET123631.87
10:42 ET110031.93
10:45 ET50031.955
10:47 ET10031.965
10:49 ET20031.98
10:51 ET135132.045
10:54 ET78431.975
10:56 ET70031.98
10:58 ET41231.9
11:00 ET20031.965
11:02 ET10032.04
11:05 ET70032.08
11:12 ET10032.19
11:16 ET10032.15
11:21 ET10032.16
11:23 ET100032.08
11:25 ET80032.07
11:30 ET484431.95
11:32 ET10032.045
11:34 ET30031.92
11:36 ET20031.94
11:38 ET30031.89
11:39 ET10031.89
11:41 ET30031.91
11:43 ET20031.92
11:45 ET10031.92
11:48 ET30031.93
11:50 ET10031.95
11:52 ET70031.97
11:54 ET10031.89
11:56 ET40031.91
11:57 ET10031.945
11:59 ET20031.91
12:01 ET10031.9
12:03 ET20031.965
12:08 ET60531.975
12:12 ET10031.93
12:14 ET40031.985
12:17 ET246332.15
12:19 ET79032.07
12:24 ET10032.16
12:26 ET10032.1
12:28 ET30032.17
12:30 ET330032
12:32 ET31031.98
12:33 ET243831.93
12:35 ET40031.94
12:37 ET40031.925
12:39 ET315531.915
12:44 ET108931.82
12:46 ET30031.81
12:48 ET30031.81
12:50 ET40031.81
12:51 ET44831.83
12:53 ET60031.83
12:55 ET10031.79
12:57 ET30031.83
01:00 ET50031.865
01:02 ET56031.93
01:04 ET11331.88
01:06 ET25031.875
01:09 ET20031.79
01:11 ET66731.81
01:13 ET10031.83
01:15 ET10031.79
01:18 ET10031.78
01:20 ET60031.8
01:22 ET20031.72
01:24 ET38331.79
01:26 ET40031.83
01:27 ET10031.79
01:29 ET79631.78
01:31 ET10031.8
01:36 ET50031.8
01:40 ET30031.84
01:42 ET80031.86
01:44 ET40831.815
01:51 ET50031.8
01:54 ET20031.8
01:56 ET20031.765
02:02 ET20031.765
02:03 ET25131.83
02:05 ET10031.83
02:09 ET10031.83
02:14 ET10031.83
02:16 ET10031.73
02:18 ET120031.605
02:21 ET10031.71
02:25 ET20031.605
02:30 ET40031.5925
02:32 ET20031.69
02:34 ET30031.69
02:36 ET10031.6
02:38 ET1343031.385
02:39 ET176131.52
02:45 ET40031.465
02:48 ET80031.42
02:54 ET30031.42
02:57 ET60031.385
03:01 ET58731.37
03:03 ET30031.425
03:06 ET20031.46
03:08 ET10031.43
03:10 ET10031.47
03:14 ET10031.47
03:15 ET170031.39
03:19 ET10031.34
03:21 ET20031.33
03:24 ET100031.34
03:26 ET20031.33
03:28 ET10031.33
03:30 ET40031.34
03:32 ET301931.465
03:35 ET176331.435
03:37 ET41731.49
03:39 ET30031.405
03:44 ET20031.45
03:46 ET224031.48
03:48 ET51931.55
03:50 ET150831.645
03:51 ET39131.55
03:53 ET180031.605
03:55 ET211831.6
03:57 ET318131.64
04:00 ET1892631.75
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMCR
Immunocore Holdings PLC
1.6B
-33.4x
---
United StatesKNSA
Kiniksa Pharmaceuticals International PLC
1.5B
-133.4x
---
United StatesINVA
Innoviva Inc
1.2B
27.4x
-8.76%
United StatesHROW
Harrow Inc
1.4B
-40.5x
---
United StatesEOLS
Evolus Inc
829.5M
-14.2x
---
United StatesOCUL
Ocular Therapeutix Inc
1.5B
-7.3x
---
As of 2024-12-04

Company Information

Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs Against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a clinical-stage pipeline of wholly owned and partnered programs across three different therapeutic areas: oncology, infectious diseases, and autoimmune and inflammation diseases. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, lung, gastric and others.

Contact Information

Headquarters
90 Park Drive, Milton Park, AbingdonABINGDON, United Kingdom OX14 4RY
Phone
123-543-8600
Fax
---

Executives

Independent Chairman of the Board
John Bell
Chief Executive Officer, Executive Director
Bahija Jallal
Chief Financial Officer, Head of Strategy
Brian Di Donato
Chief Human Resource Officer
Tina St Leger
Head of Research and Development
David Berman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.6B
Revenue (TTM)
$296.6M
Shares Outstanding
50.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.73
EPS
$-0.95
Book Value
$7.42
P/E Ratio
-33.4x
Price/Sales (TTM)
5.4
Price/Cash Flow (TTM)
---
Operating Margin
-23.24%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.